Janet Ursua
Nurse Practitioner · Rancho Cucamonga, CANPI 1114093101
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $895 and has fallen 97.1% since, to $26 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $19.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$491
- Abbott$351
- Bayer$292
- Lilly USA, LLC$211
- Pfizer$196
- Novartis$150
- plus $773 from 17 others
What the payments were for
- Food & beverage$2,464100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $491 |
| Abbott | 18 | $351 |
| Bayer | 9 | $292 |
| Lilly USA, LLC | 9 | $211 |
| Pfizer | 10 | $196 |
| Novartis | 12 | $150 |
| Esperion Therapeutics, Inc. | 6 | $111 |
| Novo Nordisk | 6 | $93 |
| Boehringer Ingelheim | 4 | $71 |
| Astellas Pharma US Inc | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $62 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Exact Sciences | 3 | $56 |
| Amgen | 3 | $48 |
| Sanofi Pasteur Inc. | 2 | $46 |
| Phadia US Inc. | 2 | $34 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Merck | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,464 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 24 | $216 |
| Levothyroxine Sodium | 17 | $154 |
| Losartan Potassium | 11 | $76 |
| Amlodipine Besylate | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rancho Cucamonga
- Kelly ChoiRancho Cucamonga$483K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
- Angelina CollinsSan Diego$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.